However, the exact mechanism of this abnormality of lipid metabolism in SMA is still unclear, but it is assumed to be related to the absence of the SMN gene product, defects in neighboring genes, or the eventual loss of neuronal trophic factor [51,52]. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.